On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayFeb 01, 2017 3:54 pm

Zogenix, Inc. (NASDAQ: ZGNX) Receives Patent for ZX008 in the Treatment of Dravet Syndrome

Zogenix, Inc. (NASDAQ: ZGNX) has been issued a patent by the U.S. Patent Office for its drug candidate ZX008. The award of this patent, according to the company, marks the first time a patent has been issued covering a fenfluramine treatment of Dravet Syndrome and the seizures associated with it (http://nnw.fm/K0ReQ). The patent is seen by the company as offering protection of associated claims through 2033. “This represents the first issued patent covering the treatment of seizures associated with Dravet Syndrome using fenfluramine as an adjunctive therapy, and it is an important milestone for our ZX008 development program,” Stephen J.…

Continue Reading

WednesdayFeb 01, 2017 2:30 pm

Social Reality, Inc. (NASDAQ: SRAX) Innovative Ad Technology Offering Stronger Digital & Social Marketing Performance

Any business today knows that, in order to thrive and build a customer base, it needs to develop strong digital marketing awareness and communicate with its target audience virtually in real-time via social media and across any other digital channels. Nowadays, advertising alone is no longer enough. With customers becoming increasingly savvy and competition being tougher than ever, businesses have to look for new, unique ways to stay relevant and improve their digital performance. With the help of Social Reality, Inc. (NASDAQ: SRAX), a leading Internet advertising company offering a wide range of tools to automate the digital advertising market,…

Continue Reading

WednesdayFeb 01, 2017 12:43 pm

CytoDyn Inc. (CYDY) Set to Profit from Helping the HIV+

CytoDyn Inc. (OTCQB: CYDY) is set to profit from helping the HIV positive with its lead product candidate, PRO 140. The company is close to submitting a rolling Biologics License Application (BLA) for PRO 140 as a combination therapy with highly active antiretroviral therapy (HAART). The biologic has already been designated a “fast track” product candidate by the FDA, and, earlier this month, the company filed a request for Breakthrough Therapy Designation with the FDA for PRO 140 as a treatment for HIV-1 infection in treatment-experienced patients with virologic failure. Getting PRO 140 to market means CytoDyn Inc. will be…

Continue Reading

WednesdayFeb 01, 2017 12:19 pm

GreeneStone Healthcare Corp. (GRST) is “One to Watch”

GreeneStone Healthcare Corp. (OTCQB: GRST), through its subsidiaries, provides medical services in the city of Toronto and the regional municipality of Muskoka, Ontario, Canada. Located 90 minutes north of Toronto in Muskoka, GreeneStone Healthcare’s Addiction and Rehabilitation Treatments segment offers out-patient counseling, coaching, intervention, psychological assessment, and other related services. GreeneStone Muskoka employs the best principles and practices currently available in the treatment of individuals with addiction. To ensure the most comprehensive and effective treatment for its clients, GreeneStone Muskoka treats underlying or co-occurring disorders in tandem with the treatment of addiction. The 36-bed addiction treatment center offers a holistic,…

Continue Reading

WednesdayFeb 01, 2017 10:08 am

Marijuana Industry Pushing Toward Federal Acceptance, Expanded Research in 2017

For the marijuana industry, 2016 was a successful year by any standards, reaching an estimated $7 billion in transactions and bringing the total number of states to legalize marijuana for medical and/or recreational purposes to 28. However, deemed America's fastest growing industry in recent years, the market still has some major obstacles to overcome in 2017, such as gaining access to legal banking services, obtaining federal drug reclassification, and more. Removing marijuana from the federal list of Schedule I drugs would be a major step forward for the industry, with massive implications and benefits trickling through to reach cannabis-related product…

Continue Reading

WednesdayFeb 01, 2017 9:36 am

Innovation and Globalization Define Top Residential Real Estate Brokerages and Portals

The top residential real estate companies and portals are achieving global reach through the embrace of cloud-based technology and franchising. In a sign of the times, these volume businesses are leveraging modern technological advancements to accomplish more than sales goals and to leave a legacy of lasting social impact across the globe. The growth of companies like the Zillow Group, Inc. (NASDAQ: Z), Realogy Holdings Corp. (NYSE: RLGY), RE/MAX Holdings, Inc. (NYSE: RMAX), Berkshire Hathaway Inc. (NYSE: BRK.A) / HomeServices and eXp World Holdings, Inc. (OTCQB:EXPI) corresponds with this cycle. By implementing novel infrastructure, agent ownership structures, and aligning the…

Continue Reading

WednesdayFeb 01, 2017 9:16 am

ChineseInvestors.com, Inc. (CIIX) Discusses Recent Achievements Driving Aggressive Plans for 2017

On Monday, January 30, 2017, Alan Klitenic, the Director of Investor Relations for ChineseInvestors.com, Inc. (OTCQB: CIIX), was interviewed by NetworkNewsWire. Mr. Klitenic described the company, and the growing underserved market it has managed to successfully tap, some of the company’s achievements over the past year, and the aggressive goals it is already pursuing for 2017. Salient points include the following: Description - ChineseInvestors.com, Inc. is a unique financial media service that is tailored to the ethnic Chinese speaking population in the U.S. and Canada. Founded by long-time financial professional Warren Wang, it’s an American company, but with a strong…

Continue Reading

TuesdayJan 31, 2017 3:52 pm

eXp World Holdings, Inc. (EXPI) Using Virtual Reality to Better Train its Agents and Brokers

Brokers have been using virtual reality for a long time, but augmented reality, or AR, is expected to be a new trend for 2017, according to the ‘Emerging Trends in Real Estate 2017’ report published by PWC (http://nnw.fm/PZ7Gy). With the emergence of Pokémon Go, it became clear that augmented reality could prompt over 10 million people to leave their homes and search for digital characters. Could it somehow do the same for the real estate industry? Despite basic AR technology having been around for some time, brokers are now using it to show tenants and potential buyers customizable experiences not…

Continue Reading

TuesdayJan 31, 2017 2:34 pm

Moxian, Inc. (NASDAQ: MOXC) Expanding Into Shanghai, Guangzhou In 2017

Moxian, Inc. (NASDAQ: MOXC) is expanding into Shanghai and Guangzhou in 2017 from its existing direct sales offices in Beijing and Shenzhen. It is targeting further growth in the expanding online-to-offline (O2O) market in China from merchant paid subscriptions and the increase in online sales, predominantly from women. The January 10, 2017, Crystal Equity Research Report (http://nnw.fm/NupY5) on Moxian projects that the company will generate revenues of $2.3 million by fiscal year end 2018. Moxian has its own online mobile platform in China’s growing O2O market, Moxian+. It offers both a consumer app, Moxian+ User, and a business app, Moxian+…

Continue Reading

TuesdayJan 31, 2017 2:00 pm

Arch Therapeutics, Inc. (ARTH) Starts Presentation at NobleCon13

Arch Therapeutics (OTC: ARTH) operates as a life science medical device company. Arch develops products based on its technology to stop bleeding and control leaking, as well as provides other advantages during surgery and trauma care. The company’s primary product candidate is AC5 Devices, a biocompatible synthetic peptide that comprises naturally occurring amino acids to achieve hemostasis in minimally invasive and open surgical procedures. For more information, visit the company’s website at www.archtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217